Barinthus Bio completes enrolment in hepatitis B and prostate cancer vaccine trials
Barinthus Biotherapeutics (formerly Vaccitech) has completed enrolment for its vaccine trials in chronic hepatitis B (CHB) and prostate cancer. The UK-based …
Post
-
-
Jaguar’s diarrhoea drug shows benefit in Phase III breast cancer subgroup
A diarrhoea drug by Jaguar Health that previously failed in a Phase III oncology trial has shown statistically significant benefit …
-
Perimeter completes enrolment for AI-assisted breast imaging trial
Perimeter Medical Imaging AI has completed enrolment for the pivotal trial of its AI-assisted imaging technology, the Perimeter B-Series OCT …
-
Biogen scrapped stroke drug helps patients walk independently in Phase III trial
A stroke drug scrapped by Biogen has helped more people to walk independently 12 months after a large hemispheric infarction …
-
Navigating the confluence of AI and community-based trials: Is this the solution to improved diversity in clinical research?
Early adoption of artificial intelligence (AI) is already changing the game in clinical trials, with AI enabling some companies to …
-
Biogen scrapped stroke drug helps patients walk independently in Phase III trial
A stroke drug scrapped by Biogen has helped more people to walk independently 12 months after a large hemispheric infarction …
-
Navigating the confluence of AI and community-based trials: Is this the solution to improved diversity in clinical research?
Early adoption of artificial intelligence (AI) is already changing the game in clinical trials, with AI enabling some companies to …
-
EmVenio’s clinical research sites at Prime Healthcare hospitals now open in Dallas and Atlanta
EmVenio Research recently announced it has opened two dedicated research centers within the Prime Healthcare hospital system, located in the greater Dallas and Atlanta areas. …
-
EmVenio Research celebrates Prime Healthcare partnership with ribbon-cutting
Clinical research organization EmVenio Research, a PCM Trials company, recently celebrated its partnership with Prime Healthcare in a grand opening event …
-
The course to forging long-term manufacturing partnerships for gene therapies
The current adeno-associated virus (AAV) vector manufacturing landscape in 2024 is a “buyer’s market” with companies competing for clinical trial …
-
A schizophrenia win for BMS’ Cobenfy, but challenges lie ahead
On 26 September 2024, Bristol Myers Squibb (BMS) announced that the US Foof and Drug Administration approved Cobenfy (xanomeline and …
-
Genentech buys Regor’s CDK inhibitors in $850m deal
Genentech is strengthening its oncology pipeline by acquiring Regor Pharmaceuticals’ portfolio of breast cancer cyclin-dependent kinase (CDK) inhibitors in an …
-
Clinical Trial Feasibility Services for the Clinical Trials Industry
Clinical trial feasibility study services help pharmaceutical and biotech companies determine the potential for success of the proposed drug and …
-
Synchron’s BCI meets primary endpoint in feasibility trial
Synchron has cemented its position as the frontrunner in brain computer interface (BCI) clinical trials, after the company reported positive …
-
Crucial drug shortages questions the exclusion of pregnant women in clinical trials
Australian mothers and babies are at risk due to a critical shortage of several crucial medicines considered safe for use …
